pdufa.bio

lorundrostat

Updated ยทnext FDA decision on the calendar

lorundrostat is a Mineralys Therapeutics, Inc. program in Hypertension. Its next catalyst is a PDUFA on Dec 22, 2026. Every date links its source.

MLYS catalyst hub

Catalyst history

PDUFA · Dec 22, 2026MLYS